A study to learn how asundexian affects the amount of metformin in the blood when healthy participants take them together
22375
Phase 1 other active
Quick answer
A study to learn how asundexian affects the amount of metformin in the blood when healthy participants take them together for Prevention of ischemic stroke in patients after an acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack in combination with antiplatelet therapy is a Phase 1 program (other) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Prevention of ischemic stroke in patients after an acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack in combination with antiplatelet therapy
- Phase
- Phase 1
- Modality
- other
- Status
- active